| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma
|
Kondo, Takafumi
|
|
|
172 |
C |
p. 311-322
|
artikel
|
| 2 |
Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade
|
Takada, Kazuki
|
|
|
172 |
C |
p. 199-208
|
artikel
|
| 3 |
A systematic review and meta-analysis assessing the impact of body mass index on long-term survival outcomes after surgery for colorectal cancer
|
Simillis, Constantinos
|
|
|
172 |
C |
p. 237-251
|
artikel
|
| 4 |
Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis
|
Mai, Aaron Shengting
|
|
|
172 |
C |
p. 65-75
|
artikel
|
| 5 |
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic review
|
Battisti, Nicolò Matteo Luca
|
|
|
172 |
C |
p. 158-170
|
artikel
|
| 6 |
Chromosomal instability in cancers of unknown primary
|
Chebly, Alain
|
|
|
172 |
C |
p. 323-325
|
artikel
|
| 7 |
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
|
Rosellini, Pietro
|
|
|
172 |
C |
p. 85-95
|
artikel
|
| 8 |
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer
|
Derangère, Valentin
|
|
|
172 |
C |
p. 221-230
|
artikel
|
| 9 |
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
|
Corti, Chiara
|
|
|
172 |
C |
p. 332-339
|
artikel
|
| 10 |
Dose modification rules and availability of growth factor support: A cross-sectional study of head-to-head cancer trials used for US FDA approval from 2009 to 2021
|
Olivier, Timothée
|
|
|
172 |
C |
p. 349-356
|
artikel
|
| 11 |
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial
|
Ligorio, Francesca
|
|
|
172 |
C |
p. 300-310
|
artikel
|
| 12 |
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients
|
Tselikas, Lambros
|
|
|
172 |
C |
p. 1-12
|
artikel
|
| 13 |
Gene expression-based prediction of pazopanib efficacy in sarcoma
|
Heilig, Christoph E.
|
|
|
172 |
C |
p. 107-118
|
artikel
|
| 14 |
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials
|
Wang, Jingyuan
|
|
|
172 |
C |
p. 22-30
|
artikel
|
| 15 |
Germline allelic expression of genes at 17q22 locus associates with risk of breast cancer
|
Esteves, Filipa
|
|
|
172 |
C |
p. 146-157
|
artikel
|
| 16 |
Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy
|
Abed, Afaf
|
|
|
172 |
C |
p. 98-106
|
artikel
|
| 17 |
Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer
|
Kim, Chang Gon
|
|
|
172 |
C |
p. 387-399
|
artikel
|
| 18 |
Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study
|
Kooijmans, Esmee C.M.
|
|
|
172 |
C |
p. 287-299
|
artikel
|
| 19 |
Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients
|
Bagnasco, Francesca
|
|
|
172 |
C |
p. 138-145
|
artikel
|
| 20 |
Letter re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review
|
Vilgrain, Isabelle
|
|
|
172 |
C |
p. 400-402
|
artikel
|
| 21 |
Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study
|
Poleé, Iris N.
|
|
|
172 |
C |
p. 252-263
|
artikel
|
| 22 |
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study
|
Longo-Muñoz, Federico
|
|
|
172 |
C |
p. 340-348
|
artikel
|
| 23 |
Lurbinectedin shows clinical activity and immune-modulatory functions in patients with pre-treated small cell lung cancer and malignant pleural mesothelioma
|
Dumoulin, Daphne W.
|
|
|
172 |
C |
p. 357-366
|
artikel
|
| 24 |
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
|
Hettmer, Simone
|
|
|
172 |
C |
p. 367-386
|
artikel
|
| 25 |
Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study
|
Tan, Daniel S.W.
|
|
|
172 |
C |
p. 276-286
|
artikel
|
| 26 |
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry
|
Müller, Volkmar
|
|
|
172 |
C |
p. 13-21
|
artikel
|
| 27 |
Overcoming acquired MET amplification after encorafenib-cetuximab in BRAF-V600E mutated colorectal cancer
|
Ros, Javier
|
|
|
172 |
C |
p. 326-328
|
artikel
|
| 28 |
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group
|
Hingorani, Pooja
|
|
|
172 |
C |
p. 264-275
|
artikel
|
| 29 |
Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis
|
Yang, Wenxing
|
|
|
172 |
C |
p. 41-50
|
artikel
|
| 30 |
Preventing late recurrence in hormone receptor-positive early breast cancer: a review
|
Battisti, Nicolò Matteo Luca
|
|
|
172 |
C |
p. 53-64
|
artikel
|
| 31 |
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer
|
Mazzoli, Giacomo
|
|
|
172 |
C |
p. 171-181
|
artikel
|
| 32 |
Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1–3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer Registry
|
Yamada, Akimitsu
|
|
|
172 |
C |
p. 31-40
|
artikel
|
| 33 |
QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer
|
Kelly, Sarah M.
|
|
|
172 |
C |
p. 209-220
|
artikel
|
| 34 |
Re: A transcriptomic signature that predicts cancer recurrence following hepatectomy in patients with colorectal liver metastases
|
Wang, Mingliang
|
|
|
172 |
C |
p. 405-406
|
artikel
|
| 35 |
Reducing the cancer mortality gap between Western and Eastern Europe. A long way off.
|
Jeziorski, Krzysztof
|
|
|
172 |
C |
p. 96-97
|
artikel
|
| 36 |
Response to letter entitled re: A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases
|
Wada, Yuma
|
|
|
172 |
C |
p. 407-409
|
artikel
|
| 37 |
Response to letter entitled: Re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review
|
Schneider, Lucas
|
|
|
172 |
C |
p. 403-404
|
artikel
|
| 38 |
Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
|
Hulshof, Emma C.
|
|
|
172 |
C |
p. 231-233
|
artikel
|
| 39 |
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma
|
Santoni, Matteo
|
|
|
172 |
C |
p. 191-198
|
artikel
|
| 40 |
Survival in smouldering myeloma and symptomatic myeloma: Is there an emerging Will Rogers phenomenon?
|
Chakraborty, Rajshekhar
|
|
|
172 |
C |
p. 234-236
|
artikel
|
| 41 |
Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990–2016: The NORDCAN survival studies
|
Lundberg, Frida E.
|
|
|
172 |
C |
p. 76-84
|
artikel
|
| 42 |
Tazemetostat for the treatment of INI-1-deficient sinonasal tumor
|
Saleh, Khalil
|
|
|
172 |
C |
p. 329-331
|
artikel
|
| 43 |
The prognostic impact of the smoking status of cancer patients receiving systemic treatment, radiation therapy, and surgery: A systematic review and meta-analysis
|
Schaefers, Christoph
|
|
|
172 |
C |
p. 130-137
|
artikel
|
| 44 |
Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group
|
Ben-Arush, Myriam
|
|
|
172 |
C |
p. 119-129
|
artikel
|
| 45 |
Unexpectedly high seroprevalance of Kaposi's sarcoma-associated herpesvirus (HHV-8) in patients with stage IV melanoma
|
Kronenberg, Katharina
|
|
|
172 |
C |
p. 51-52
|
artikel
|
| 46 |
What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patients
|
Eigentler, Thomas K.
|
|
|
172 |
C |
p. 182-190
|
artikel
|
Tijdschrift beschrijving